In addition, the altered lipid metabolism was reported to be linked with many signaling pathways, such as TNF signaling (52), Wnt signaling (53), and MAPK (54), leading to worse outcomes that included T2D and non-alcoholic fatty liver disease (55). The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.